A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancer

Lung cancer remains the leading common cause of cancer-related death, with non-small-cell lung cancer (NSCLC) accounting for 80% of all cases. To date, platinum-based doublet chemotherapy is the cornerstone of first-line therapy. However, these agents have limited use in patients who have relapsed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Huan, Guo, Jun, Li, Changzheng, Wang, Zhehai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560517/
https://www.ncbi.nlm.nih.gov/pubmed/26357465
http://dx.doi.org/10.2147/DDDT.S90670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560517/
https://www.ncbi.nlm.nih.gov/pubmed/26357465
http://dx.doi.org/10.2147/DDDT.S90670

Ejemplares similares